Advertisements
Feeds:
Posts
Comments

Search Results for 'Antiarrhythmic drugs'

Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study

Posted in Uncategorized on October 10, 2014| Leave a Comment »


PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world. Source: http://www.plosone.org See on Scoop.it – Cardiovascular and vascular imaging Advertisements

Read Full Post »

Effectiveness of Anti-arrhythmic Drugs: Amiodarone and Lidocaine, for treating sudden cardiac arrest, increasing likelihood of Patients Surviving Emergency Transport to Hospital

Posted in Cardiovascular Research, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, tagged , , , on April 4, 2016| Leave a Comment »


Effectiveness of Anti-arrhythmic Drugs: Amiodarone and Lidocaine, for treating sudden cardiac arrest, increasing likelihood of Patients Surviving Emergency Transport to Hospital Curator: Aviva Lev-Ari, PhD, RN   Original Study http://www.nejm.org/doi/full/10.1056/NEJMoa1514204 Editorial Out-of-Hospital Cardiac Arrest — Are Drugs Ever the Answer? Jose A. Joglar, M.D., and Richard L. Page, M.D. http://www.nejm.org/doi/pdf/10.1056/NEJMe1602790 Monday, April 4, 2016 Antiarrhythmic […]

Read Full Post »

Antiarrhythmic Drug Therapy: Calcium Antagonists and Beta-Adrenergic Blockers

Posted in Ca2+ triggered activation, Calcium Signaling, Cardiovascular Research, Curation, Electrophysiology, Pharmaceutical Analytics, Pharmaceutical Drug Discovery, Pharmacologic toxicities, Signaling, Signaling & Cell Circuits, Translational Science on February 21, 2016| Leave a Comment »


There are three calcium-channel blocking drugs available, but only verapamil possesses significant clinical antiarrhythmic effects. Since the drug affects Sourced through Scoop.it from: my-medstore-canada.net See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »

Warfarin and Dabigatran, Similarities and Differences

Posted in Acute Myocardial Infarction, Bio Instrumentation in Experimental Life Sciences Research, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, Health Economics and Outcomes Research, Origins of Cardiovascular Disease, Peripheral Arterial Disease & Peripheral Vascular Surgery, Personalized and Precision Medicine & Genomic Research, Pharmacotherapy of Cardiovascular Disease, Spontaneous Coronary Artery Dissection (SCAD), Statistical Methods for Research Evaluation, tagged , , , , on April 4, 2016| Leave a Comment »


Warfarin and Dabigatran, Similarities and Differences Author and Curator: Danut Dragoi, PhD   What anticoagulants do? An anticoagulant helps your body control how fast your blood clots; therefore, it prevents clots from forming inside your arteries, veins or heart during certain medical conditions. If you have a blood clot, an anticoagulant may prevent the clot […]

Read Full Post »

What Are Your Medication Options for Heart Arrhythmias?

Posted in Uncategorized on January 9, 2016| Leave a Comment »


Heart arrhythmias can be treated with antiarrhythmic drugs, AV nodal blocking drugs, beta blockers, statins, and omega-3 fatty acids. Sourced through Scoop.it from: heartdisease.about.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »

Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases

Posted in on October 3, 2013| 2 Comments »


Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases   https://www.amazon.com/dp/B07MGSFDWR On Amazon.com since 12/23/2018 Volume Authors, Curators and Co-Editors: Justin D. Pearlman, MD, PhD, FACC: Editorials and Clinical Pearls, Author Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN Other e-Books in the BioMedicine e-Series Series A: e-Books on Cardiovascular Diseases Content Consultant: Justin D Pearlman, […]

Read Full Post »

Sleep apnea and non-invasive positive pressure breathing

Posted in Cerebrovascular and Neurodegenerative Diseases, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, Drug Delivery Platform Technology, Health Economics and Outcomes Research, International Global Work in Pharmaceutical, Pharmaceutical Industry Competitive Intelligence, Technology Transfer: Biotech and Pharmaceutical, tagged , , , , , , , on June 11, 2013| 1 Comment »


Larry H Bernstein, MD Writer and Curator Sleep apnea and non-invasive positive pressure breathing http://pharmaceutical intelligence.com/Sleep apnea and non-invasive positive pressure breathing Presentation of sleep apnea Obstructive sleep apnea is caused by a blockage of the airway.  This may occur when the soft tissue in the rear of the throat collapses and closes during sleep. […]

Read Full Post »

Percutaneous Endocardial Ablation of Scar-Related Ventricular Tachycardia

Posted in Bio Instrumentation in Experimental Life Sciences Research, Cardiac & Vascular Repair Tools Subsegment, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Frontiers in Cardiology and Cardiovascular Disorders, Health Economics and Outcomes Research, Medical Devices R&D and Inventions, Medical Devices R&D Investment, Origins of Cardiovascular Disease, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Pharmacotherapy of Cardiovascular Disease, tagged , , , , , , , , on July 18, 2012| 13 Comments »


Percutaneous Endocardial Ablation of Scar-Related Ventricular Tachycardia Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 11/15/2013 Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST) A 2-Center Randomized Clinical Trial Lucas V.A. Boersma, MD, PhD, FESC; Manuel Castella, MD, PhD; WimJan van Boven, MD; Antonio Berruezo, MD; Alaaddin Yilmaz, MD; Mercedes Nadal, MD; Elena Sandoval, MD; […]

Read Full Post »

Calcium Channel Blocker Potential for Angina

Posted in Acute Myocardial Infarction, Biological Networks, Ca2+ triggered activation, Calcium Signaling, Cardiomyopathy, Cardiovascular Research, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Clinical & Translational, Curation, Disease Biology, Small Molecules in Development of Therapeutic Drugs, FDA, CE Mark & Global Regulatory Affairs: process management and strategic planning - GCP, GLP, ISO 14155, Frontiers in Cardiology and Cardiovascular Disorders, Gene Regulation, HTN, Myocardial metabolism, Myocardial ischemia, Myocardial adenine nucleotide metabolism, Pharmacotherapy of Cardiovascular Disease, tagged , , , on December 11, 2015| Leave a Comment »


Calcium Channel Blocker Potential for Angina Larry H. Bernstein, MD, FCAP, Curator LPBI     Pranidipine     ANTHONY MELVIN CRASTO, PhD https://newdrugapprovals.files.wordpress.com/2015/12/str116.jpg   Pranidipine , OPC-13340, FRC 8411 Acalas® NDA Filing in Japan A calcium channel blocker potentially for the treatment of angina pectoris and hypertension.   CAS No. 99522-79-9 Molecular FormulaC25H24N2O6 Average mass 448.468   […]

Read Full Post »

Conversations about Medicine

Posted in Interviews with Scientific Leaders, tagged , , , on October 14, 2015| Leave a Comment »


Conversations about Medicine Larry H. Bernstein, MD, FCAP, Curator LPBI Emperor‘s Mukherjee on the Three Laws of Medicine Eric J. Topol, MD http://www.medscape.com/viewarticle/852303 Editor’s Note: Last month, Medscape filmed a special One-on-One interview with Siddhartha Mukherjee, MD, in front of a live audience at the Rainbow Room in New York City. During the interview, Dr […]

Read Full Post »

Next »